It has been postulated that the lack of enhancement for parenchymal lesions in toxoplasmosis in HSCT patients compared to patients with acquired immune deficiency syndrome (AIDS) may be related to differences in their immunocompromised state (global loss of immune cells in HSCT versus CD4 cell loss in AIDS) [6]. This evidence concerns the gene CD4 and toxoplasmosis.